Tafalgie Therapeutics

Tafalgie Therapeutics is a startup founded in 2018 based in France. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Your browser does not support HTML5 video. A new pharmaceutical approach to treating pain Towards a safe and effective alternative to existing painkillers. Our molecule Tafalgie Therapeutics, a CNRS spin-off, is a clinical-stage biotechnology company specializing in the development of next-generation painkillers The company is pioneering the development of a new therapeutic class of non-opioid […]